Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Embecta Corporation (EMBC)
NASDAQ:EMBC
Holding EMBC?
Track your performance easily
EMBC Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$9.93 - $19.79
Previous Close$13.64
Volume268.52K
Average Volume (3M)411.63K
Market Cap
$787.05M
Enterprise Value$2.15B
Total Cash (Recent Filing)$275.10M
Total Debt (Recent Filing)$1.63B
Price to Earnings (P/E)11.3
Beta1.07
Next Earnings
Dec 17, 2024EPS Estimate
$0.36Last Dividend Ex-Date
Aug 27, 2024Dividend Yield4.4%
Share Statistics
EPS (TTM)1.21
Shares Outstanding57,701,830
10 Day Avg. Volume354,048
30 Day Avg. Volume411,625
Standard Deviation0.14
R-Squared0.12
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)-1.03
Price to Sales (P/S)0.70
Price to Cash Flow (P/CF)-93.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.92
Enterprise Value/Gross Profit2.86
Enterprise Value/Ebitda130.07
Forecast
1Y Price Target
$13.00Price Target Upside-7.34% Downside
Rating ConsensusModerate Sell
Number of Analyst Covering2
Embecta Corporation News
PremiumCompany Announcements
Embecta Corporation Announces Chief Accounting Officer Resignation
Bulls Say, Bears Say
Bulls Say
Financial PerformancePlenty to like about EMBC as an asset, including its track record of quarterly beats, its relatively healthy operating margins, market leadership, global presence, dividend, and the nearly complete separation process.
Product DemandThe 14-count pen needle pack should receive good uptake on the back of broadening demand for GLP-1s in the pen format.
Regulatory ApprovalManagement was pleased with recent FDA approval of EMBC's open loop system.
Bears Say
Competitive EnvironmentThe majority of conversations with investors around the pump program skew on the bearish side, given high running/establishment costs and an intensifying competitive environment.
Stock PerformanceEMBC's stock price fell nearly 50% between January and May, though there was little new news to explain the weakness.
Valuation ConcernsEMBC trades well below its peers on any valuation measure, including P/E, EV/EBITDA, and EV/Sales.
---
Ownership Overview
1.59% Insiders
34.07% Mutual Funds
0.23% Other Institutional Investors
36.35% Public Companies and
Individual Investors
EMBC FAQ
What was Embecta Corporation’s price range in the past 12 months?
Embecta Corporation lowest stock price was $9.93 and its highest was $19.79 in the past 12 months.
What is Embecta Corporation’s market cap?
Currently, no data Available
When is Embecta Corporation’s upcoming earnings report date?
Embecta Corporation’s upcoming earnings report date is Dec 17, 2024 which is in 56 days.
How were Embecta Corporation’s earnings last quarter?
Embecta Corporation released its earnings results on Aug 09, 2024. The company reported $0.74 earnings per share for the quarter, beating the consensus estimate of $0.464 by $0.276.
Is Embecta Corporation overvalued?
According to Wall Street analysts Embecta Corporation’s price is currently Overvalued.
Does Embecta Corporation pay dividends?
Embecta Corporation pays a Quarterly dividend of $0.15 which represents an annual dividend yield of 4.4%. See more information on Embecta Corporation dividends here
What is Embecta Corporation’s EPS estimate?
Embecta Corporation’s EPS estimate is $0.36.
How many shares outstanding does Embecta Corporation have?
Embecta Corporation has 57,701,830 shares outstanding.
What happened to Embecta Corporation’s price movement after its last earnings report?
Embecta Corporation reported an EPS of $0.74 in its last earnings report, beating expectations of $0.464. Following the earnings report the stock price went up 7.329%.
Which hedge fund is a major shareholder of Embecta Corporation?
Among the largest hedge funds holding Embecta Corporation’s share is Yacktman Asset Management LP. It holds Embecta Corporation’s shares valued at 35M.
---
Embecta Corporation Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Sell
Average Price Target:
$13.00 (-7.34% Downside)
$13.00 (-7.34% Downside)
Blogger Sentiment
Bullish
EMBC Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 135.9K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.7%
Last 30 Days ▼ 6.1%
Last 30 Days ▼ 6.1%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-7.79%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
1.23%
Trailing 12-Months
Company Description
Embecta Corporation
Embecta Corp is a medical technology company. The company develops innovative technology, services, and solutions that help advance both clinical therapy for patients and clinical processes for healthcare providers. Its products include BD Pyxis, PureWick, Phasix among others.
---
EMBC Company Deck
---
EMBC Earnings Call
Q3 2024
0:00 / 0:00
---
EMBC Stock 12 Month Forecast
Average Price Target
$13.00
▼(-7.34% Downside)
Technical Analysis
Best Analysts Covering EMBC
1 Year
1 Year Success Rate
6/7 ratings generated profit
1 Year Average Return
+18.26%
assigned a sell rating 2 months ago
Copying Kallum Titchmarsh's trades and holding each position for 1 Year would result in 85.71% of your transactions generating a profit, with an average return of +18.26% per trade.
---